Higher calcium intake is associated with reduced colorectal cancer (CRC) risk across tumor sites and calcium sources, ...

Exelixis’ next-generation tyrosine kinase inhibitor zanzalintinib is being tested for colorectal cancer, renal cell carcinoma ...

A new blood-based test could diagnose pancreatic cancer much earlier, improving outcomes for people with the disease.

What are the signs and symptoms of bladder cancer, and what are its risk factors? Here's what you need to know, according to an expert.

Luminescent gold nanoparticles (L-AuNPs) represent a novel class of luminescent nanomaterials that have attracted ...

Newly published detailed clinical trial data show why Exelixis abandoned a plan to seek an FDA approval for a combination of ...

The FDA granted fast track status to IBI363 for the treatment of patients with advanced squamous lung cancer after prior ...

Cardiff Oncology's Onvansertib shows promise in treating RAS-mutated cancers, especially mCRC. See why I rate CRDF stock as a ...

He noted that other assays studied in pancreatic cancer have only examined a handful of samples. "When they publish a second ...

Natera (NTRA) commented on recent updates by the NCCN on circulating tumor DNA molecular residual disease testing in the Clinical Practice ...

In its updated guidelines for colon cancer 1 and for rectal cancer 2, NCCN now includes ctDNA as a high risk factor for recurrence in the adjuvant setting, recognizing its prognostic value. This ...

Barry Stein initially ignored his symptoms in 1995, until he was eventually diagnosed with stage 4 colorectal cancer. (Photo provided by Stein) Colorectal cancer cancer grows more slowly than some ...